Viking Therapeutics (NASDAQ:VKTX) Shares Gap Up on Analyst Upgrade

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) shares gapped up before the market opened on Tuesday after Oppenheimer raised their price target on the stock from $30.00 to $35.00. The stock had previously closed at $21.33, but opened at $21.86. Viking Therapeutics shares last traded at $21.48, with a volume of 510,823 shares traded. A […]

Related Keywords

San Diego ,California ,United States ,Stifel Nicolaus ,Lawson Macartney ,Michaela Dinerman ,Therapeutics Inc ,Virtu Financial ,Cetera Advisor Networks ,Nasdaq ,Maxim Group ,Envestnet Asset Management Inc ,Viking Therapeutics ,Get Rating ,Director Lawson Macartney ,Advisor Networks ,Gate Manager ,Envestnet Asset Management ,Brian Lian ,Viking Therapeutics Daily ,Nasdaq Vktx ,Vktx ,Medical ,Stocks ,Technicals ,